BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension
© 2024 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute..
Bone morphogenetic protein receptor 2 (BMPR2) mutation is the most common gene mutation implicated in the pathogenesis of pulmonary arterial hypertension (PAH). We describe, for the first time, an excellent clinical response to tyrosine kinase inhibitor imatinib in a patient with heritable PAH from BMPR2 mutation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Pulmonary circulation - 14(2024), 1 vom: 25. Jan., Seite e12335 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, Shine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bmpr2 mutation |
|---|
| Anmerkungen: |
Date Revised 13.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1002/pul2.12335 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367044986 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367044986 | ||
| 003 | DE-627 | ||
| 005 | 20240114234928.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/pul2.12335 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1258.xml |
| 035 | |a (DE-627)NLM367044986 | ||
| 035 | |a (NLM)38213946 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kumar, Shine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a BMPR2 mutation and clinical response to imatinib in a case of heritable pulmonary arterial hypertension |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.01.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. | ||
| 520 | |a Bone morphogenetic protein receptor 2 (BMPR2) mutation is the most common gene mutation implicated in the pathogenesis of pulmonary arterial hypertension (PAH). We describe, for the first time, an excellent clinical response to tyrosine kinase inhibitor imatinib in a patient with heritable PAH from BMPR2 mutation | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Bmpr2 mutation | |
| 650 | 4 | |a hereditary | |
| 650 | 4 | |a imatinib | |
| 650 | 4 | |a pulmonary hypertension | |
| 700 | 1 | |a Biswas, Lalitha |e verfasserin |4 aut | |
| 700 | 1 | |a Pushkaran, Anju Choorakottayil |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Raman Krishna |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pulmonary circulation |d 2011 |g 14(2024), 1 vom: 25. Jan., Seite e12335 |w (DE-627)NLM207988838 |x 2045-8932 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g number:1 |g day:25 |g month:01 |g pages:e12335 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/pul2.12335 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2024 |e 1 |b 25 |c 01 |h e12335 | ||